BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11456312)

  • 1. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
    Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
    Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered naive CD4
    Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A
    J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.
    Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
    Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms of paraneoplastic myasthenia gravis.
    Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
    Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
    Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
    J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic diseases associated with thymoma.
    Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
    J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T-cells in the initiation of autoantibody responses in thymoma patients.
    Vincent A; Willcox N
    Pathol Res Pract; 1999; 195(8):535-40. PubMed ID: 10483583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
    Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
    J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive peripheral CD8
    Tabata R; Tabata C; Yamamoto N; Shibuya S; Yasumizu R; Kojima M
    Int Immunopharmacol; 2018 Oct; 63():14-18. PubMed ID: 30056258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.
    Takahashi K; Monden Y; Saito S; Kamamura Y; Uyama T
    J Clin Immunol; 1996 Jul; 16(4):190-7. PubMed ID: 8840220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell development in human thymoma.
    Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H
    Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
    Luther C; Poeschel S; Varga M; Melms A; Tolosa E
    J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XLOC_003810 promotes T cell activation and inhibits PD-1/PD-L1 expression in patients with myasthenia gravis-related thymoma.
    Hu B; Niu L; Jiang Z; Xu S; Hu Y; Cao K
    Scand J Immunol; 2020 Jul; 92(1):e12886. PubMed ID: 32243615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients.
    Tackenberg B; Schlegel K; Happel M; Eienbröker C; Gellert K; Oertel WH; Meager A; Willcox N; Sommer N
    J Neuroimmunol; 2009 Nov; 216(1-2):85-91. PubMed ID: 19781791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
    Fujii Y; Hayakawa M; Inada K; Nakahara K
    Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.